Literature DB >> 28695731

Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.

Mei-Ling Han1, Hsin-Hui Shen, Karl A Hansford2, Elena K Schneider1, Sivashangarie Sivanesan1, Kade D Roberts1, Philip E Thompson1, Anton P Le Brun3, Yan Zhu1, Marc-Antoine Sani4, Frances Separovic4, Mark A T Blaskovich2, Mark A Baker5, Samuel M Moskowitz6, Matthew A Cooper2, Jian Li, Tony Velkov1.   

Abstract

Octapeptins are cyclic lipopeptides with a broader spectrum of activity against fungi and polymyxin-resistant Gram-negative and Gram-positive bacteria. In the present study, we investigated the interaction of octapeptin A3 with asymmetric outer membrane models of Gram-negative pathogen Pseudomonas aeruginosa using neutron reflectometry, together with fluorimetric and calorimetry methods. For the first time, our neutron reflectometry results reveal that the interaction of octapeptin A3 with the Gram-negative outer membrane involves an initial transient polar interaction with the phospholipid and lipid A headgroups, followed by the penetration of the entire octapeptin molecule into the fatty acyl core of the outer membrane. This mechanism contrasts with that of polymyxin B, which specifically targets lipid A, whereas octapeptins appear to target both lipid A and phospholipids. Furthermore, the mechanism of octapeptins does not appear to be highly dependent on an initial complementary electrostatic interaction with lipid A, which accounts for their ability to bind to lipid A of polymyxin-resistant Gram-negative bacteria that is modified with cationic moieties that act to electrostatically repel the cationic polymyxin molecule. The presented findings shed new light on the mechanism whereby octapeptins penetrate the outer membrane of polymyxin-resistant Gram-negative pathogens and highlight their potential as candidates for development as new antibiotics against problematic multi-drug-resistant pathogens.

Entities:  

Keywords:  mode of action; multidrug resistance; octapeptin; polymyxin

Mesh:

Substances:

Year:  2017        PMID: 28695731      PMCID: PMC5955700          DOI: 10.1021/acsinfecdis.7b00065

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  28 in total

1.  Isolation of a new antibiotic 333-25, related to antibiotic EM 49. (Studies on antibiotics from the genus Bacillus. XI).

Authors:  J Shoji; H Hinoo; Y Wakisaka; K Koizumi; M Mayama
Journal:  J Antibiot (Tokyo)       Date:  1976-05       Impact factor: 2.649

2.  Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?

Authors:  Mohammad A K Azad; Bo Yun; Kade D Roberts; Roger L Nation; Philip E Thompson; Tony Velkov; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2014-10       Impact factor: 5.191

3.  EM49: a new polypeptide antibiotic active against cell membranes.

Authors:  E Meyers; W L Parker; W E Brown; P Linnett; J L Strominger
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

4.  EM49, a new peptide antibiotic. I. Fermentation, isolation, and preliminary characterization.

Authors:  E Meyers; W E Brown; P A Principe; M L Rathnum; W L Parker
Journal:  J Antibiot (Tokyo)       Date:  1973-08       Impact factor: 2.649

5.  The constituent amino acids and fatty acid of antibiotic 333-25. (Studies on antibiotics from the genus Bacillus. XII.

Authors:  J Shoji; H Hinoo; R Sakazaki
Journal:  J Antibiot (Tokyo)       Date:  1976-05       Impact factor: 2.649

6.  Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.

Authors:  Simona Bratu; Pooja Tolaney; Usha Karumudi; John Quale; Mohamad Mooty; Satyen Nichani; David Landman
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

7.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.

Authors:  Irith Wiegand; Kai Hilpert; Robert E W Hancock
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 8.  Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature.

Authors:  Azza Elemam; Joseph Rahimian; William Mandell
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

9.  An accurate in vitro model of the E. coli envelope.

Authors:  Luke A Clifton; Stephen A Holt; Arwel V Hughes; Emma L Daulton; Wanatchaporn Arunmanee; Frank Heinrich; Syma Khalid; Damien Jefferies; Timothy R Charlton; John R P Webster; Christian J Kinane; Jeremy H Lakey
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-01       Impact factor: 15.336

10.  Effect of divalent cation removal on the structure of gram-negative bacterial outer membrane models.

Authors:  Luke A Clifton; Maximilian W A Skoda; Anton P Le Brun; Filip Ciesielski; Ivan Kuzmenko; Stephen A Holt; Jeremy H Lakey
Journal:  Langmuir       Date:  2014-12-19       Impact factor: 3.882

View more
  6 in total

1.  Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.

Authors:  Miranda E Pitt; Minh Duc Cao; Mark S Butler; Soumya Ramu; Devika Ganesamoorthy; Mark A T Blaskovich; Lachlan J M Coin; Matthew A Cooper
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

Review 2.  Role of Lipid Composition, Physicochemical Interactions, and Membrane Mechanics in the Molecular Actions of Microbial Cyclic Lipopeptides.

Authors:  Daniel Balleza; Andrea Alessandrini; Miguel J Beltrán García
Journal:  J Membr Biol       Date:  2019-05-16       Impact factor: 1.843

3.  Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa.

Authors:  Mei-Ling Han; Yan Zhu; Darren J Creek; Yu-Wei Lin; Alina D Gutu; Paul Hertzog; Tony Purcell; Hsin-Hui Shen; Samuel M Moskowitz; Tony Velkov; Jian Li
Journal:  mSystems       Date:  2019-01-08       Impact factor: 6.496

4.  Reversing resistance to counter antimicrobial resistance in the World Health Organisation's critical priority of most dangerous pathogens.

Authors:  Henrietta Venter
Journal:  Biosci Rep       Date:  2019-04-12       Impact factor: 3.840

5.  A polytherapy based approach to combat antimicrobial resistance using cubosomes.

Authors:  Xiangfeng Lai; Mei-Ling Han; Yue Ding; Seong Hoong Chow; Anton P Le Brun; Chun-Ming Wu; Phillip J Bergen; Jhih-Hang Jiang; Hsien-Yi Hsu; Benjamin W Muir; Jacinta White; Jiangning Song; Jian Li; Hsin-Hui Shen
Journal:  Nat Commun       Date:  2022-01-17       Impact factor: 14.919

Review 6.  Studying the surfaces of bacteria using neutron scattering: finding new openings for antibiotics.

Authors:  Nicolò Paracini; Luke A Clifton; Jeremy H Lakey
Journal:  Biochem Soc Trans       Date:  2020-10-30       Impact factor: 5.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.